The Basil Intel AI-powered platform enhances Medical Affairs teams with a 360-degree view of product safety, competitive efficacy, and clinical landscapes – enabling stronger KOL engagement, faster evidence generation, and compliant collaboration with Commercial partners.
Comprehensive adverse event monitoring and comparative safety analysis across your products and competitive landscape.
Real-time signal detection with AI-powered threshold analysis.
Identify emerging safety signals before they become public issues.
Generate instant comparative safety profiles for KOL discussions and publication planning.
Strengthen your scientific narrative with proactive safety positioning. Support evidence-based discussions with physicians and regulators.
Global clinical trial tracking with advanced filtering by phase, sponsor, endpoints, inclusion/exclusion criteria, and therapeutic area. Direct cross-reference to approved label claims.
30+ years of historical clinical trial data with hourly updates. Identify competitive trials the moment they register – not when results publish.
Stay ahead of the competitive clinical landscape. Inform investigator-initiated trial design and publication strategies with complete market context.
Role-based access controls that respect the regulatory firewall between Medical and Commercial functions while enabling structured insight sharing.
Medical Affairs generates scientifically rigorous insights; Commercial receives validated, compliance-appropriate intelligence. All on one platform with full audit trails.
Bridge the Medical-Commercial gap without compliance risk. Accelerate commercial strategy with the right scientific data.
Evidence packages combining label data, clinical trial results, and safety profiles for Key Opinion Leader discussions, advisory boards, and congress engagements.
Generate comprehensive briefing documents in minutes. Ensure every MSL conversation is grounded in the latest validated data.
Enhance scientific engagement with physicians. Build trust through peer-to-peer dialogue supported by authoritative evidence.
A Medical Affairs team needed comprehensive safety comparisons for an upcoming advisory board with leading oncologists. Traditional analysis would have required weeks of manual FAERS queries and literature review. Using Basil, the team generated validated comparative safety profiles across five competitor products in under 2 minutes – complete with demographic filtering and signal source reference.
"We've always struggled to share insights without crossing a compliance firewall. Basil finally bridged that gap. We can accelerate commercial strategy with the correct scientific data, all while staying perfectly compliant."
Senior Director, Medical Affairs
Top 25 Pharma
